Serotonin now: Part 1 neurobiology and developmental genetics;Serotonin kompakt- teil 1* neurobiologische und entwicklungsgenetische grundlagen

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 6, 2010, Pages 319-331

  Kriegebaum, C ^a   Gutknecht, L ^a   Schmitt, A ^a   Lesch, K P ^a   Reif, A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Development; Metabolism; Neurotransmitter; Physiology; Serotonin transporter

Indexed keywords

INDOLEAMINE; MONOAMINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN TRANSPORTER;

CIRCADIAN RHYTHM; COGNITION; DEVELOPMENTAL GENETICS; HUMAN; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SEROTONINERGIC NERVE CELL;

ANIMALS; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; GENETICS; HUMANS; NEUROBIOLOGY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 77953149583     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245240     Document Type: Review

References (128)

1. Erspamer V, Vialli M. Presence of enteramine in the skin of Amphibia. Nature 1951 167 1033
2. Rapport M M. Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle. JBiol Chem 1949 180 961-969
3. Twarog B M. Responses of a molluscan smooth muscle to acetylcholine and 5-hydroxytryptamine. JCell Physiol 1954 44 141-163
4. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967 113 1237-1264
5. Coppen A, Shaw D M., Herzberg B et al. Tryptophan in the treatment of depression. Lancet 1967 2 1178-1180
6. Lesch K P. Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs. Eur Neuropsychopharmacol 2001 11 457-474
7. Cordes S P. Molecular genetics of the early development of hindbrain serotonergic neurons. Clin Genet 2005 68 487-494
8. Ye W, Shimamura K, Rubenstein J L. et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998 93 755-766
9. Alenina N, Bashammakh S, Bader M. Specification and differentiation of serotonergic neurons. Stem Cell Rev 2006 2 5-10
10. Pattyn A, Simplicio N, Doorninck J H. et al. Ascl1 /Mash1 is required for the development of central serotonergic neurons. Nat Neurosci 2004 7 589-595
11. Lauder J M. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann N Y Acad Sci 1990 600 297-313; discussion 314
12. Shemer A V., Azmitia E C., Whitaker-Azmitia P M. Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behavior. Brain Res Dev Brain Res 1991 59 59-63
13. Whitaker-Azmitia P M., Azmitia E C. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett 1986 67 307-312
14. Liu J P., Lauder J M. Serotonin and nialamide differentially regulate survival and growth of cultured serotonin and catecholamine neurons. Brain Res Dev Brain Res 1991 62 297-305
15. Lauder J M. Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 1993 16 233-240
16. Lauder J M., Krebs H van. Serotonin as a differentiation signal in early neurogenesis. Dev Neurosci 1978 1 15-30
17. Mazer C, Muneyyirci J, Taheny K et al. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 1997 760 68-73
18. Gutknecht L, Kriegebaum C, Waider J et al. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 2009 19 266-282
19. Côté F, Fligny C, Bayard E et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci U S A 2007 104 329-334
20. Lavdas A A., Blue M E., Lincoln J et al. Serotonin promotes the differentiation of glutamate neurons in organotypic slice cultures of the developing cerebral cortex. JNeurosci 1997 17 7872-7880
21. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003 4 1002-1012
22. Lesch K P., Merschdorf U. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 2000 18 581-604
23. Gross C, Hen R. The developmental origins of anxiety. Nat Rev Neurosci 2004 5 545-552
24. Galter D, Unsicker K. Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol Cell Neurosci 2000 15 446-455
25. Azmitia E C., Gannon P J., Kheck N M. et al. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 1996 14 35-46
26. Riad M, Emerit M B., Hamon M. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. Brain Res Dev Brain Res 1994 82 245-258
27. Dahlstrom A, Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964 20 398-399
28. Hornung J P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003 26 331-343
29. Ormsbee H S 3 rd, Fondacaro J D. Action of serotonin on the gastrointestinal tract. Proc Soc Exp Biol Med 1985 178 333-338
30. Walther D J., Peter J U., Winter S et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003 115 851-862
31. Finocchiaro L M., Arzt E S., Fernandez-Castelo S et al. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. JInterferon Res 1988 8 705-716 (Pubitemid 19042691)
32. Geba G P., Ptak W, Anderson G M. et al. Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. JImmunol 1996 157 557-565
33. Rudd M L., Nicolas A N., Brown B L. et al. Peritoneal macrophages express the serotonin transporter. JNeuroimmunol 2005 159 113-118
34. El-Nour H, Lundeberg L, Abdel-Magid N et al. Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol 2007 87 390-396
35. Verhofstad A A., Steinbusch H W., Penke B et al. Serotonin-immunoreactive cells in the superior cervical ganglion of the rat. Evidence for the existence of separate serotonin- and catecholamine-containing small ganglionic cells. Brain Res 1981 212 39-49
36. Gershon M D. Serotonin: its role and receptors in enteric neurotransmission. Adv Exp Med Biol 1991 294 221-230
37. Chidlow G, Hiscott P S., Osborne N N. Expression of serotonin receptor mRNAs in human ciliary body: a polymerase chain reaction study. Graefes Arch Clin Exp Ophthalmol 2004 242 259-264
38. Newman C, Wang D, Cutz E. Serotonin (5-hydroxytryptamine) expression in pulmonary neuroendocrine cells (NE) and a netumor cell line. Adv Exp Med Biol 1993 337 73-78
39. Roper S D. Signal transduction and information processing in mammalian taste buds. Pflugers Arch 2007 454 759-776
40. Barbosa R M., Silva A M., Tome A R. et al. Control of pulsatile 5-HT/insulin secretion from single mouse pancreatic islets by intracellular calcium dynamics. J Physiol 1998 510 (Pt 1) 135-143
41. Ikeda K, Tojo K, Otsubo C et al. 5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 2005 328 522-525
42. Matsuda M, Imaoka T, Vomachka A J. et al. Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell 2004 6 193-203
43. Meyer-Bernstein E L., Morin L P. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. JNeurosci 1996 16 2097-2111
44. Lerchl A. Biological rhythms in the context of light at night (LAN). Neuro Endocrinol Lett 2002 23 Suppl 2 23-27
45. Bulian D, Pierpaoli W. The pineal gland and cancer. I. Pinealectomy corrects congenital hormonal dysfunctions and prolongs life of cancer-prone C 3 H/He mice. J Neuroimmunol 2000 108 131-135
46. Pierpaoli W, Bulian D, Arrighi S. Transferrin treatment corrects aging-related immunologic and hormonal decay in old mice. Exp Gerontol 2000 35 401-408
47. Reuss S, Concemius W, Stehle J et al. Effects of electrical stimulation of the superior cervical ganglia on the number of synaptic ribbons and the activity of melatonin-forming enzymes in the rat pineal gland. Anat Embryol (Berl) 1989 179 341-345
48. Korf H W., Gall C von. Mice, melatonin and the circadian system. Mol Cell Endocrinol 2006 252 57-68
49. Reiter R J., Leppaluoto J. Melatonin as a hormone and an antioxidant: implications for organisms at high latitudes. Int J Circumpolar Health 1997 56 4-11
50. Walther D J., Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003 66 1673-1680
51. Walther D J., Peter J U., Bashammakh S et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003 299 76
52. Gutknecht L, Waider J, Kraft S et al. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. JNeural Transm 2008 115 1127-1132
53. Weihe E, Schafer M K., Erickson J D. et al. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 1994 5 149-164
54. Peter D, Liu Y, Sternini C et al. Differential expression of two vesicular monoamine transporters. JNeurosci 1995 15 6179-6188
55. Erickson J D., Schafer M K., Bonner T I. et al. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A 1996 93 5166-5171
56. Haase J, Killian A M., Magnani F et al. Regulation of the serotonin transporter by interacting proteins. Biochem Soc Trans 2001 29 722-728
57. Waldmeier P C. Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). JNeural Transm Suppl 1987 23 55-72
58. Rodriguez M J., Saura J, Billett E et al. MAO-A and MAO-B localisation in human lung and spleen. Neurobiology (Bp) 2000 8 243-248
59. Rodriguez M J., Saura J, Finch C C. et al. Localization of monoamine oxidase A and B in human pancreas, thyroid, and adrenal glands. JHistochem Cytochem 2000 48 147-151
60. Torres G E., Gainetdinov R R., Caron M G. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003 4 13-25
61. Blakely R D., De Felice L J., Hartzell H C. Molecular physiology of norepinephrine and serotonin transporters. JExp Biol 1994 196 263-281
62. Chen J C., Tonkiss J, Galler J R. et al. Prenatal protein malnutrition in rats enhances serotonin release from hippocampus. JNutr 1992 122 2138-2143
63. Ni W, Watts S W. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 2006 33 575-583
64. Ramamoorthy S, Cool D R., Mahesh V B. et al. Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. JBiol Chem 1993 268 21 626-21 631
65. Jayanthi L D., Ramamoorthy S, Mahesh V B. et al. Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells. JBiol Chem 1994 269 14424-14429
66. Miller K J., Hoffman B J. Adenosine A 3 receptors regulate serotonin transport via nitric oxide and cGMP. JBiol Chem 1994 269 27351-27356
67. Qian Y, Galli A, Ramamoorthy S et al. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. JNeurosci 1997 17 45-57
68. Zhu C B., Hewlett W A., Francis S H. et al. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. Eur J Pharmacol 2004 504 1-6
69. Samuvel D J., Jayanthi L D., Bhat N R. et al. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. JNeurosci 2005 25 29-41
70. Bengel D, Heils A, Petri S et al. Gene structure and 5-flanking regulatory region of the murine serotonin transporter. Brain Res Mol Brain Res 1997 44 286-292
71. Lesch K P., Balling U, Gross J et al. Organization of the human serotonin transporter gene. JNeural Transm Gen Sect 1994 95 157-162
72. Hoyer D, Clarke D E., Fozard J R. et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994 46 157-203
73. Raymond J R., Mukhin Y V., Gelasco A et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 2001 92 179-212
74. Francken B J., Jurzak M, Vanhauwe J F. et al. The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 1998 361 299-309
75. Aune T M., Golden H W., McGrath K M. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. JImmunol 1994 153 489-498
76. Marazziti D, Marracci S, Palego L et al. Localization and gene expression of serotonin 1A (5 HT1A) receptors in human brain postmortem. Brain Res 1994 658 55-59
77. Compaan J C., Groenink L, Gugten J van der et al. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus. Eur J Neurosci 1996 8 2340-2347
78. Drevets W C., Frank E, Price J C. et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999 46 1375-1387
79. Barnes N M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999 38 1083-1152
80. Kahn R S., Trestman R, Lawlor B A. et al. Effects of ipsapirone in healthy subjects: a dose-response study. Psychopharmacology (Berl) 1994 114 155-160
81. Izquierdo I, Medina J H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 1997 68 285-316
82. Rausch J L., Johnson M E., Kasik K E. et al. Temperature regulation in depression: functional 5 HT1A receptor adaptation differentiates antidepressant response. Neuropsychopharmacology 2006 31 2274-2280
83. Sargent P A., Kjaer K H., Bench C J. et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100 635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000 57 174-180
84. Lundberg J, Borg J, Halldin C et al. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl) 2007 195 425-433
85. Bell R, Hobson H. 5-HT1A receptor influences on rodent social and agonistic behavior: a review and empirical study. Neurosci Biobehav Rev 1994 18 325-338
86. Boer S F., Lesourd M de, Mocaer E et al. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2- dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100 635. JPharmacol Exp Ther 1999 288 1125-1133
87. Heisler L K., Chu H M., Brennan T J. et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 1998 95 15049-15054
88. Parks C L., Robinson P S., Sibille E et al. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 1998 95 10734-10739
89. Ramboz S, Oosting R, Amara D A. et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 1998 95 14476-14481
90. Razzaque Z, Pickard J D., Ma Q P. et al. 5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan. Br J Clin Pharmacol 2002 53 266-274
91. Roy A, Brand N J., Yacoub M H. Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves. JHeart Valve Dis 2000 9 256-260
92. Uddman R, Longmore J, Cardell L O. et al. Expression of 5-HT1B receptors in human nasal mucosa. Acta Otolaryngol 2001 121 403-406
93. Varnas K, Hurd Y L., Hall H. Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse 2005 56 21-28
94. Lowther S, De Paermentier F, Crompton M R. et al. The distribution of 5-HT1D and 5-HT1E binding sites in human brain. Eur J Pharmacol 1992 222 137-142
95. Varnas K, Hall H, Bonaventure P et al. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125 743. Brain Res 2001 915 47-57
96. Brunner D, Buhot M C., Hen R et al. Anxiety, motor activation, and maternal-infant interactions in 5 HT1B knockout mice. Behav Neurosci 1999 113 587-601
97. Malleret G, Hen R, Guillou J L. et al. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. JNeurosci 1999 19 6157-6168
98. Ramboz S, Saudou F, Amara D A. et al. 5-HT1B receptor knock out behavioral consequences. Behav Brain Res 1996 73 305-312
99. Saudou F, Amara D A., Dierich A et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994 265 1875-1878
100. Agosti R M. 5 HT1F- and 5 HT7-receptor agonists for the treatment of migraines. CNS Neurol Disord Drug Targets 2007 6 235-237
101. Pascual J, del Arco C, Romon T et al. Autoradiographic distribution of [3 H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996 16 317-322
102. Bruinvels A T., Landwehrmeyer B, Gustafson E L. et al. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 1994 33 367-386
103. Ishida T, Hirata K, Sakoda T et al. Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries. Cardiovasc Res 1999 41 267-274
104. Pierce P A., Xie G X., Meuser T et al. 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience 1997 81 813-819
105. Cook E H Jr, Fletcher K E., Wainwright M et al. Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. JNeurochem 1994 63 465-469
106. Nagatomo T, Rashid M, AbulMuntasir H et al. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. Pharmacol Ther 2004 104 59-81
107. Busatto G F., Pilowsky L S., Costa D C. et al. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nucl Med 1997 24 119-124
108. Pompeiano M, Palacios J M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 1994 23 163-178
109. Dwivedi Y, Pandey G N. Quantitation of 5 HT2A receptor mRNA in human postmortem brain using competitive RT-PCR. Neuroreport 1998 9 3761-3765
110. Lauterbach E C., Abdelhamid A, Annandale J B. Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5 HT2a receptor blockade. Pharmacopsychiatry 2000 33 38-41
111. Glusa E, Roos A. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br J Pharmacol 1996 119 330-334
112. Schaerlinger B, Hickel P, Etienne N et al. Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. Br J Pharmacol 2003 140 277-284
113. Schmuck K, Ullmer C, Kalkman H O. et al. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci 1996 8 959-967
114. Launay J M., Schneider B, Loric S et al. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. FASEB J 2006 20 1843-1854
115. Westberg L, Bah J, Rastam M et al. Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology 2002 26 789-793
116. Harada K, Aota M, Inoue T et al. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR 260 010: a comparison with diazepam and buspirone. Eur J Pharmacol 2006 553 171-184
117. Rex A, Bert B, Fink H. History and new developments. The pharmacology of 5-ht3 antagonists. Pharm Unserer Zeit 2007 36 342-353
118. Tecott L H., Maricq A V., Julius D. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci U S A 1993 90 1430-1434
119. Votolato N A., Stern S, Caputo R M. Serotonergic antidepressants and urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000 11 386-388
120. Varnas K, Halldin C, Pike V W. et al. Distribution of 5-HT4 receptors in the postmortem human brain - an autoradiographic study using [125I]SB 207 710. Eur Neuropsychopharmacol 2003 13 228-234
121. Cartier D, Jegou S, Parmentier F et al. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol 2005 153 939-947
122. Kaumann A J., Levy F O. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 2006 111 674-706
123. Bockaert J, Claeysen S, Compan V et al. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 2004 3 39-51
124. Taniyama K, Makimoto N, Furuichi A et al. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. JGastroenterol 2000 35 575-582
125. Nelson D L. 5-HT5 receptors. Curr Drug Targets CNS Neurol Disord 2004 3 53-58
126. Woolley M L., Marsden C A., Fone K C. 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 2004 3 59-79
127. Thomas D R., Hagan J J. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004 3 81-90
128. Lesch K P., Zeng Y, Reif A et al. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur J Pharmacol 2003 480 185-204